Fraisse Alain, Latchman Monica, Sharma Shiv-Raj, Bayburt Selin, Amedro Pascal, di Salvo Giovanni, Baruteau Alban Elouen
Royal Brompton & Harefield NHS Foundation Trust, London, UK.
Acibadem University, School of Medicine, Acıbadem Universitesi Kerem AydınlarKampüsü, Ataşehir, Istanbul, Turkey.
J Thorac Dis. 2018 Sep;10(Suppl 24):S2874-S2881. doi: 10.21037/jtd.2018.08.111.
Transcatheter closure has become an accepted alternative to surgical repair for ostium secundum atrial septal defects (ASD). However, large ASDs (>38 mm) and defects with deficient rims are usually not offered transcatheter closure but are referred for surgical closure. Transcatheter closure also remains controversial for other complicated ASDs with comorbidities, additional cardiac features and in small children. This article not only provides a comprehensive, up-to-date description of the current indications and contra-indications for ASD device closure, but also further explores the current limits for transcatheter closure in controversial cases. With the devices and technology currently available, several cohort studies have reported successful percutaneous closure in the above-mentioned complex cases. However the feasibility and safety of transcatheter technique needs to be confirmed through larger studies and longer follow-up.
经导管封堵术已成为继发孔型房间隔缺损(ASD)外科修复的一种公认替代方法。然而,大型ASD(>38 mm)和边缘缺损的缺损通常不采用经导管封堵术,而是转至外科进行封堵。对于其他合并症、额外心脏特征的复杂ASD以及小儿患者,经导管封堵术也仍存在争议。本文不仅全面、最新地描述了ASD装置封堵的当前适应证和禁忌证,还进一步探讨了在有争议病例中经导管封堵术的当前局限性。利用目前可用的装置和技术,多项队列研究报告了上述复杂病例经皮封堵成功。然而,经导管技术的可行性和安全性需要通过更大规模研究和更长时间随访来证实。